PCH
RVNC
Polar Capital Holdings’s Revance Therapeutics, Inc. RVNC Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-3,567,139
| Closed | -$9.17M | – | 315 |
|
|
2024
Q2 | $9.17M | Sell |
3,567,139
-317,680
| -8% | -$816K | 0.05% | 191 |
|
|
2024
Q1 | $19.1M | Buy |
3,884,819
+715,580
| +23% | +$3.52M | 0.1% | 149 |
|
|
2023
Q4 | $27.9M | Sell |
3,169,239
-991,072
| -24% | -$8.71M | 0.17% | 112 |
|
|
2023
Q3 | $47.7M | Sell |
4,160,311
-7,531
| -0.2% | -$86.4K | 0.35% | 77 |
|
|
2023
Q2 | $105M | Hold |
4,167,842
| – | – | 0.53% | 34 |
|
|
2023
Q1 | $134M | Sell |
4,167,842
-680,791
| -14% | -$21.9M | 0.87% | 23 |
|
|
2022
Q4 | $89.5M | Buy |
4,848,633
+386,886
| +9% | +$7.14M | 0.71% | 39 |
|
|
2022
Q3 | $120K | Buy |
4,461,747
+1,344,695
| +43% | +$36.3K | 0.77% | 25 |
|
|
2022
Q2 | $43.1K | Buy |
3,117,052
+660,555
| +27% | +$9.13K | 0.25% | 86 |
|
|
2022
Q1 | $47.9K | Buy |
2,456,497
+196,797
| +9% | +$3.84K | 0.22% | 98 |
|
|
2021
Q4 | $36.9K | Buy |
2,259,700
+516,703
| +30% | +$8.43K | 0.14% | 120 |
|
|
2021
Q3 | $48.6K | Buy |
1,742,997
+588,263
| +51% | +$16.4K | 0.2% | 106 |
|
|
2021
Q2 | $34.2K | Hold |
1,154,734
| – | – | 0.15% | 123 |
|
|
2021
Q1 | $32.3M | Hold |
1,154,734
| – | – | 0.2% | 123 |
|
|
2020
Q4 | $32.7M | Buy |
+1,154,734
| New | +$32.7M | 0.2% | 116 |
|